Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1988 2
1989 6
1990 11
1991 3
1992 7
1993 5
1994 12
1995 6
1996 4
1997 11
1998 8
1999 10
2000 12
2001 8
2002 12
2003 11
2004 15
2005 15
2006 17
2007 18
2008 14
2009 21
2010 21
2011 15
2012 16
2013 23
2014 13
2015 12
2016 11
2017 14
2018 16
2019 15
2020 12
2021 6
2022 8
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

367 results

Results by year

Filters applied: . Clear all
Page 1
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV Jr, Marteau P, Munkholm P, Murdoch TB, Ordás I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, Panes J, Bouguen G, O'Donnell S, Pariente B, Winer S, Hanauer S, Colombel JF. Peyrin-Biroulet L, et al. Among authors: marteau p. Am J Gastroenterol. 2015 Sep;110(9):1324-38. doi: 10.1038/ajg.2015.233. Epub 2015 Aug 25. Am J Gastroenterol. 2015. PMID: 26303131 Review.
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P. Sokol H, et al. Among authors: marteau p. Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6. doi: 10.1073/pnas.0804812105. Epub 2008 Oct 20. Proc Natl Acad Sci U S A. 2008. PMID: 18936492 Free PMC article. Clinical Trial.
Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study.
Sokol H, Landman C, Seksik P, Berard L, Montil M, Nion-Larmurier I, Bourrier A, Le Gall G, Lalande V, De Rougemont A, Kirchgesner J, Daguenel A, Cachanado M, Rousseau A, Drouet É, Rosenzwajg M, Hagege H, Dray X, Klatzman D, Marteau P; Saint-Antoine IBD Network; Beaugerie L, Simon T. Sokol H, et al. Among authors: marteau p. Microbiome. 2020 Feb 3;8(1):12. doi: 10.1186/s40168-020-0792-5. Microbiome. 2020. PMID: 32014035 Free PMC article. Clinical Trial.
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease.
Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario M, Feagan BG, Bojic D, Trang-Poisson C, Shen B, Altwegg R, Sands BE, Colombel JF, Carbonnel F; GETAID OBSERV-IBD, VICTORY Cohorts Collaboration*. Dulai PS, et al. Aliment Pharmacol Ther. 2020 Mar;51(5):553-564. doi: 10.1111/apt.15609. Epub 2019 Dec 22. Aliment Pharmacol Ther. 2020. PMID: 31867766 Free PMC article.
Lactose intolerance.
Vesa TH, Marteau P, Korpela R. Vesa TH, et al. Among authors: marteau p. J Am Coll Nutr. 2000 Apr;19(2 Suppl):165S-175S. doi: 10.1080/07315724.2000.10718086. J Am Coll Nutr. 2000. PMID: 10759141 Review.
[Refractory proctitis].
Seksik P, Daniel F, Marteau P, Beaugerie L, Cosnes J. Seksik P, et al. Among authors: marteau p. Gastroenterol Clin Biol. 2007 Apr;31(4):393-7. doi: 10.1016/s0399-8320(07)89398-5. Gastroenterol Clin Biol. 2007. PMID: 17483776 Free article. Review. French. No abstract available.
Inflammatory bowel disease.
Marteau P. Marteau P. Endoscopy. 2000 Feb;32(2):131-7. doi: 10.1055/s-2000-142. Endoscopy. 2000. PMID: 10696841 Review.
Inflammatory bowel disease.
Marteau P. Marteau P. Endoscopy. 2002 Jan;34(1):63-8. doi: 10.1055/s-2002-19392. Endoscopy. 2002. PMID: 11778131 Review.
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, Färkkilä M, Gisbert JP, Marteau P, Nahon S, de Vos M, Franchimont D, Mary JY, Colombel JF, Lémann M; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Laharie D, et al. Among authors: marteau p. Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10. Lancet. 2012. PMID: 23063316 Clinical Trial.
Emerging indications of endoscopic radiofrequency ablation.
Becq A, Camus M, Rahmi G, de Parades V, Marteau P, Dray X. Becq A, et al. Among authors: marteau p. United European Gastroenterol J. 2015 Aug;3(4):313-24. doi: 10.1177/2050640615571159. United European Gastroenterol J. 2015. PMID: 26279839 Free PMC article. Review.
367 results